Jardiance® Tablets for Type 2 Diabetes

This medicine is an oral SGLT2 inhibitor for adults with type 2 diabetes. It helps lower blood sugar and supports cardiovascular and kidney outcomes when used as directed. You can access Canadian pricing with US delivery from Canada, which may help if paying without insurance.

What Jardiance Is and How It Works

Jardiance® contains empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It reduces glucose reabsorption in the kidneys so more glucose is excreted in urine. This action helps lower A1C and fasting glucose. In adults with type 2 diabetes and established cardiovascular disease, it can reduce the risk of cardiovascular death per approved labeling.

Empagliflozin also has labeled uses in heart failure and certain chronic kidney disease settings. Benefits vary by indication, background therapy, and individual risk. Always follow the Patient Information and your prescriber’s instructions. CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

People sometimes search for terms like Jardiance generic when comparing options. That phrase usually refers to the active ingredient, empagliflozin. Availability of non-branded versions depends on market approvals and supply, which can change over time.

For broader background on diabetes care, see our condition page for Type 2 Diabetes. If you are considering class options, you can also review the category for SGLT2 Inhibitors.

Who It’s For

This treatment is indicated for adults with type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It may be used, per label, to reduce cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. It is also indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, and for certain adults with chronic kidney disease to slow disease progression and reduce cardiovascular risk according to approved labeling.

It is not indicated for type 1 diabetes or for treating diabetic ketoacidosis. People with a history of serious hypersensitivity to empagliflozin should not use it. Use is typically not recommended during the second and third trimesters of pregnancy. Patients with severe renal impairment, dialysis, or active ketoacidosis require special consideration; defer to the official label and your prescriber.

Dosage and Usage

The usual starting dose for type 2 diabetes is 10 mg once daily, taken in the morning or at any consistent time, with or without food. If additional glycemic effect is needed and tolerated, a higher daily dose may be considered per label. For heart failure or chronic kidney disease indications, a 10 mg once-daily dose is commonly used; verify exact use on the current label.

Swallow tablets whole with water. Maintain adequate hydration, especially during hot weather or illness, as the class can increase urination and fluid losses. If you use insulin or a sulfonylurea, your clinician may adjust those medicines to lower hypoglycemia risk. Hold this medicine when you are unable to maintain oral intake or during acute illness that increases dehydration or ketoacidosis risk; follow sick-day guidance from your care team.

Before elective surgery or certain procedures, labels commonly advise stopping SGLT2 inhibitors for a period beforehand. Discuss timing with your prescriber well in advance of any procedure. When in doubt, follow the Prescribing Information and seek medical advice.

Strengths and Forms

Empagliflozin is supplied as film-coated oral tablets. Available strengths include:

• Jardiance 25 mg
• 10 mg tablet

Not all strengths or pack sizes are stocked at all times. Availability may vary by dispensing pharmacy.

Missed Dose and Timing

If you miss a dose, take it when remembered that same day. If it is close to the time for the next dose, skip the missed dose and resume your regular schedule. Do not double up doses. Try to take it at the same time each day to build a routine.

Storage and Travel Basics

Store tablets at room temperature in a dry place, away from excessive heat and moisture. Keep the bottle tightly closed and out of reach of children and pets. Do not use tablets that are damaged or beyond the labeled expiration date.

When traveling, keep your medication in your carry-on bag with a copy of your prescription. Use the original labeled container for security and identification. Pack extra doses in case of delays, and maintain your usual dosing schedule across time zones with help from your care team if needed.

Benefits

This medicine can lower A1C and fasting blood glucose when added to lifestyle measures. It may reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. In adults with heart failure, it can reduce the risk of cardiovascular death and hospitalization for heart failure. In certain adults with chronic kidney disease, it may slow kidney function decline and lower cardiovascular risk per labeling.

Once-daily dosing is convenient for many patients. The class may also lead to modest weight and blood pressure reductions, though individual responses differ. Always interpret benefits within the context of your full treatment plan.

Side Effects and Safety

• Genital yeast infections: more common in females and uncircumcised males
• Urinary tract infections: including cystitis; seek care if symptoms escalate
• Increased urination and thirst: related to urinary glucose excretion
• Nausea, constipation, or diarrhea: usually mild and transient
• Hypotension or dizziness: more likely with diuretics, dehydration, or low blood pressure

Serious but less common risks include diabetic ketoacidosis (sometimes with only mild hyperglycemia), severe urinary infections including pyelonephritis and urosepsis, Fournier’s gangrene of the perineum, acute kidney injury, and hypersensitivity reactions. Stop the medicine and seek urgent care if you have signs of ketoacidosis such as nausea, vomiting, abdominal pain, trouble breathing, confusion, or unusual fatigue. Hypoglycemia can occur when used with insulin or insulin secretagogues; monitor closely and consult your clinician about adjustments to those agents as needed.

For a patient-friendly overview of effects and precautions, review our Side Effects Guide. If you also use basal insulin, see your plan for dose coordination; some patients on insulin detemir benefit from structured monitoring. For reference, you can view Insulin Detemir within our catalog.

Drug Interactions and Cautions

Take care when combining with loop or thiazide diuretics due to dehydration and hypotension risk. Using this treatment with insulin or sulfonylureas can increase hypoglycemia risk. Consider additional monitoring when starting or adjusting any of these drugs.

Be cautious with low-carbohydrate or ketogenic diets, persistent vomiting, or heavy alcohol intake, which can raise ketoacidosis risk. Pause therapy around major surgery or prolonged fasting per your clinician’s direction. In heart failure care, it is often used alongside guideline-directed therapy such as ACE inhibitors, ARBs, ARNIs, beta blockers, and mineralocorticoid receptor antagonists. For context on ARNI therapy, see ARNI Therapy. For kidney-protective adjuncts in appropriate patients, see Finerenone. For RAAS blockade information, review Valsartan.

What to Expect Over Time

Most patients see their blood sugar patterns change within weeks as part of a complete plan. Results depend on diet, activity, adherence, and background medications. Expect more frequent urination early in therapy; this is part of the mechanism and may lessen over time. Continue to monitor blood glucose as instructed and keep scheduled lab work for kidney function and A1C.

Set a daily reminder to support consistent dosing. Maintain hydration, particularly during illness, hot weather, or exercise. Tell your prescriber promptly about symptoms of infection, severe genital irritation, or signs of dehydration. If you develop sustained nausea, vomiting, or reduced intake, contact your care team about holding doses until you are well.

Compare With Alternatives

Other SGLT2 inhibitors are available if your prescriber recommends a class change. Examples include Dapagliflozin and SGLT2 Invokana. These options differ by labeling, background evidence, and individual tolerability. Discuss the best choice for your condition, comorbidities, and current regimen.

Pricing and Access

We list transparent options so you can compare formulations and the jardiance price in one place. Many patients review the empagliflozin price when considering alternatives within the same class. To explore combination therapy pricing, see Empagliflozin + Metformin. Checkout is encrypted to protect your information.

You can view our Diabetes Medications category for context across therapies. We provide clear product pages so you can decide what to request from your prescriber. For occasional promotions across select items, visit our Promotions page.

Orders are processed through licensed Canadian pharmacies with dispensing oversight, and we support US shipping from Canada. Final pricing can vary based on strength, pack size, and pharmacy supply.

Availability and Substitutions

Stock status can change due to demand, manufacturer supply, or regulatory factors. If a preferred strength is unavailable, your prescriber may recommend a suitable alternative in the same class, a combination product, or a different therapeutic approach. When people ask about the generic of jardiance, they are usually referring to empagliflozin. Market availability of non-branded versions can vary by region and time.

If this product is not appropriate for you, discuss alternatives such as class peers or combination therapies like empagliflozin with metformin. Your prescriber will determine the best fit based on your medical history and treatment goals.

Patient Suitability and Cost-Saving Tips

Good candidates include adults with type 2 diabetes who need additional glycemic control, especially those with cardiovascular disease, heart failure, or chronic kidney disease where class benefits are established per label. Those with recurrent urinary or genital infections, frequent dehydration, or a history of ketoacidosis should discuss risks carefully. It is not for type 1 diabetes.

To manage costs, consider multi-month fills if clinically appropriate, which may reduce per-fill fees and interruptions. Set refill reminders to avoid gaps in therapy. Ask your prescriber about combination products if you are taking separate agents, as a single co-formulation may simplify dosing. If any financial barriers arise, discuss therapeutic alternatives within the SGLT2 class and other evidence-based options.

Questions to Ask Your Clinician

• Is this medicine appropriate for my diabetes, heart failure, or kidney disease?
• How should I monitor blood sugar and kidney function while on therapy?
• What symptoms suggest dehydration, urinary infection, or ketoacidosis?
• Do I need dose changes to insulin or sulfonylureas to lower hypoglycemia risk?
• Should I stop the medicine before a procedure or during illness?
• How does this interact with my diuretic, RAAS blocker, or beta blocker?
• Would a combination product simplify my regimen without compromising control?

Authoritative Sources

For official prescribing details, see FDA resources; consult the Full Prescribing Information on DailyMed for Jardiance. For manufacturer information, review the product page published by Boehringer Ingelheim and Lilly; see Manufacturer’s Product Information. For Canadian regulatory status, consult Health Canada’s database; visit Health Canada Drug Product Database.

Ready to request your prescription be filled? You can order from CanadianInsulin with prompt, express shipping with temperature-controlled handling when required. Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.